Clinical Trial Update: Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM® Phase-I/IIa Clinical Trial. [Phase 1, Phase 2]

View source ↗

Summary

Follow-up safety and efficacy study in subjects who completed the NEUROSTEM Phase I/IIa trial for Alzheimer's disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• NEUROSTEM

Snippet

Sponsor: Medipost Co Ltd. | Conditions: Alzheimer's Disease | Phase 1, Phase 2 | Status: COMPLETED